CLINICAL-PHARMACOLOGY OF 5-FLUOROURACIL

被引：821
作者：
DIASIO, RB
HARRIS, BE
机构：
来源：
CLINICAL PHARMACOKINETICS | 1989年 / 16卷 / 04期
关键词：
D O I：
10.2165/00003088-198916040-00002
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：215 / 237
页数：23
相关论文
共 154 条
[41]   FAMILIAL DEFICIENCY OF DIHYDROPYRIMIDINE DEHYDROGENASE - BIOCHEMICAL BASIS FOR FAMILIAL PYRIMIDINEMIA AND SEVERE 5-FLUOROURACIL-INDUCED TOXICITY [J].
DIASIO, RB ;
BEAVERS, TL ;
CARPENTER, JT .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (01) :47-51
[42]  
DOLNICK BJ, 1983, J BIOL CHEM, V258, P3299
[43]   THE SYNTHESIS OF 5-FLUOROPYRIMIDINES [J].
DUSCHINSKY, R ;
PLEVEN, E ;
HEIDELBERGER, C .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1957, 79 (16) :4559-4560
[44]  
ENSMINGER WD, 1983, SEMIN ONCOL, V10, P176
[45]  
ENSMINGER WD, 1978, CANCER RES, V38, P3784
[46]  
ERLICHMAN C, 1982, JNCI-J NATL CANCER I, V68, P227
[47]  
EVANS RM, 1981, CANCER RES, V41, P3288
[48]  
FINCH RE, 1979, BRIT J CLIN PHARMACO, V7, P613, DOI 10.1111/j.1365-2125.1979.tb04651.x
[49]  
FINN C, 1975, CANCER CHEMOTH REP 1, V59, P279
[50]   ALLOPURINOL MODULATION OF HIGH-DOSE FLUOROURACIL TOXICITY [J].
FOX, RM ;
WOODS, RL ;
TATTERSALL, MHN ;
BRODIE, GW .
CANCER TREATMENT REVIEWS, 1979, 6 :143-147
12345678910